Detalhe da pesquisa
1.
Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
PLoS Biol
; 22(1): e3002463, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289907
2.
SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
PLoS Pathog
; 18(8): e1010349, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36007063
3.
A case of swine influenza A(H1N2)v in England, November 2023.
Euro Surveill
; 29(3)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240057
4.
Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
J Neuroinflammation
; 20(1): 184, 2023 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537664
5.
Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
PLoS Pathog
; 17(12): e1010148, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890427
6.
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
PLoS Pathog
; 17(2): e1009352, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33635919
7.
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
Biochem J
; 478(13): 2405-2423, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34198322
8.
Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney Disease.
Clin Infect Dis
; 73(4): e880-e889, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728434
9.
Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding.
J Gen Virol
; 101(5): 456-466, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702542
10.
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
Lancet
; 403(10432): 1133-1136, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484752
11.
Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.
Emerg Infect Dis
; 25(10): 1878-1883, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31423969
12.
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
Lancet
; 400(10369): 2193-2196, 2022 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209762
13.
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
Lancet
; 399(10327): 800-802, 2022 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065703
14.
Three-dose vaccination elicits neutralising antibodies against omicron.
Lancet
; 399(10326): 715-717, 2022 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065005
15.
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet
; 399(10328): 905-907, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090602
16.
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
Lancet
; 398(10296): 207-209, 2021 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197809
17.
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
Lancet
; 397(10292): 2331-2333, 2021 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34090624
18.
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
Lancet
; 398(10305): 1038-1041, 2021 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391504
19.
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
PLoS One
; 19(3): e0294897, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512960
20.
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants.
medRxiv
; 2023 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292842